Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Greenberg Robert J.

2. Date of Event Requiring Statement (Month/Day/Year)
11/18/2014

3. Issuer Name and Ticker or Trading Symbol
SECOND SIGHT MEDICAL PRODUCTS INC [EYES]

(Last)

(First)

(Middle)

12744 SAN FERNANDO ROAD, BLDG. 3

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
CEO & President

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

SYLMAR, CA 91342

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	304,000	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Option ⁽¹⁾	⁽¹⁾	01/01/2017	Common Stock	125,000	$ 4.25	D
Option ⁽²⁾	⁽²⁾	01/01/2015	Common Stock	59,063	$ 4.75	D
Option ⁽³⁾	⁽³⁾	09/01/2015	Common Stock	150,000	$ 4.75	D
Option ⁽⁴⁾	⁽⁴⁾	01/01/2016	Common Stock	17,969	$ 4.75	D
Option ⁽⁵⁾	⁽⁵⁾	05/01/2016	Common Stock	8.223	$ 5	D
Option ⁽⁶⁾	⁽⁶⁾	01/01/2017	Common Stock	30,265	$ 5	D
Option ⁽⁷⁾	⁽⁷⁾	02/01/2018	Common Stock	23,750	$ 5	D
Option ⁽⁸⁾	⁽⁸⁾	11/01/2018	Common Stock	150,000	$ 5	D
Option ⁽⁹⁾	⁽⁹⁾	02/01/2019	Common Stock	33,750	$ 5	D
Option ⁽¹⁰⁾	⁽¹⁰⁾	02/01/2020	Common Stock	53,125	$ 5	D
Option ⁽¹¹⁾	⁽¹¹⁾	02/01/2020	Common Stock	50,625	$ 5	D
Option ⁽¹²⁾	⁽¹²⁾	03/01/2021	Common Stock	31,172	$ 5	D

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Greenberg Robert J. 12744 SAN FERNANDO ROAD, BLDG. 3 SYLMAR, CA 91342	X		CEO & President

Signatures

/s/ Robert J. Greenberg		11/18/2014
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	b. 31,250 options have vested on each January 1, 2008, January 1, 2009, January 1, 2010 and January 1, 2011.
(2)	c. 14,765.75 options have vested on each January 1, 2006, January 1, 2007, January 1, 2008 and January 1, 2009.
(3)	d. 37,500 options have vested on each September 1, 2006, September 1, 2007, September 1, 2008 and September 1, 2009.
(4)	e. 4,492.25 options have vested on each n January 1, 2007, January 1, 2008, January 1, 2009 and January 1, 2010.
(5)	g. 7,566.25 options have vested on each January 1, 2008, January 1, 2009, January 1, 2010 and January 1, 2011.
(6)	h. 5,937.50 options have vested on each February 1, 2009, February 1, 2010, February 1, 2011 and February 1, 2012.
(7)	i. 37,500 options have vested on each November 1, 2009, November 1, 2010, November 1, 2011 and November 1, 2012.
(8)	j. 8,437.50 options have vested on each February 1, 2010, February 1, 2011, February 1, 2012 and February 1, 2013.
(9)	k. 13,281.25 options have vested on each February 1, 2011, February 1, 2012, February 1, 2013 and February 1, 2014.
(10)	l. 12,656.25 options have vested on each February 1, 2011, February 1, 2012, February 1, 2013 and February 1, 2014.
(11)	m. 10,390.75 options have vested on each March 1, 2012, March 1, 2013 and March 1, 2014.
(12)	n. 9,687.50 options have vested on each March 1, 2013 and March 1, 2014.
Remarks: Excludes unvested options, and shares underlying unvested options of 491,300 shares, not vested and not exercisable for over 60 days from this date.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.